These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6732937)

  • 21. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endralazine, a new peripheral vasodilator: absence of effect of acetylator status on antihypertensive effect.
    Holmes DG; Bogers WA; Wideroe TE; Huunan-Seppala A; Wideroe B
    Lancet; 1983 Mar; 1(8326 Pt 1):670-1. PubMed ID: 6132036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of antihypertensive agents on blood velocity: implications for atherogenesis.
    Spence JD
    Can Med Assoc J; 1982 Oct; 127(8):721-4. PubMed ID: 7139486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of second-order polynomial equations to the study of pharmacodynamic interactions: the effect of flecainide acetate and propranolol on cardiac output and vascular resistance.
    Holtzman JL; Berry DA; Kvam DC; Mottonen L; Borrell G
    J Pharmacol Exp Ther; 1984 Nov; 231(2):286-90. PubMed ID: 6491982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ; Jaguste V; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Endralazine monotherapy in comparison with prazosin and hydralazine in arterial hypertension].
    Postol'nikov SF; Izotov AI; Malysheva NV
    Sov Med; 1986; (10):86-9. PubMed ID: 3544243
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of intravenous endralazine in essential hypertension.
    Hoffmann JJ; Thien T; van T'Laar A
    Br J Clin Pharmacol; 1983 Jul; 16(1):39-44. PubMed ID: 6349669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac output in normal pregnancy measured by impedance cardiography.
    Myhrman P; Granerus G; Karlsson K; Lundgren Y
    Scand J Clin Lab Invest; 1982 Oct; 42(6):513-20. PubMed ID: 7156865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A chronobiological approach to correcting disorders of time organization of clofelin hemodynamics in patients with stage II essential hypertension].
    Tokbaeva KK; Zaslavskaia RM; Khalberg F; Teiblium MM
    Klin Med (Mosk); 1996; 74(8):52-4. PubMed ID: 9036212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antihypertensive activity of minoxidil, hydralazine, prazosin, phentolamine and clonidine in spontaneously hypertensive rats. Comparison with therapeutic dosages].
    Luca C; Graziani G; Griffini P
    Boll Chim Farm; 1981 Jun; 120(6):343-50. PubMed ID: 7306397
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of indomethacin on hemodynamic parameters after intravenous administration of propranolol and enalaprilat in rabbits.
    Kasznicki J; Wiktorowska-Owczarek A
    Pol J Pharmacol; 2001; 53(5):487-93. PubMed ID: 11990067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of hypertension using propranolol combined with hydralazine and a thiazidine diuretic. 1st results].
    Díaz de Losada JM
    Rev Clin Esp; 1975 Dec; 139(6):559-62. PubMed ID: 1215599
    [No Abstract]   [Full Text] [Related]  

  • 34. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
    Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
    Paran E; Holzberg G; Mazor M; Zmora E; Insler V
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute hemodynamic effects of prostacyclin in severe or malignant hypertension].
    Chaignon M; Tannière-Ruffie ML; Lucsko M; Guédon J
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():147-50. PubMed ID: 6810818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydralazine and prazosin in the treatment of hypertension.
    Vandenburg MJ; Sharman VL; Wright P; Drew PJ; Barnes JN
    Br J Clin Pharmacol; 1983 Nov; 16(5):537-42. PubMed ID: 6357257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative evaluation of impedance cardiographic and dye dilution methods in determining hemodynamic indices].
    Kaloianova A
    Vutr Boles; 1981; 20(4):93-8. PubMed ID: 7029910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Betacap efficiency in elderly patients with coronary heart disease and essential hypertension].
    Zaslavskaia RM; Goncharov LF; Zholdin BK; Bisengalieva GK
    Ter Arkh; 1998; 70(1):24-6. PubMed ID: 9532646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypertension therapy with propanolol and hydralazine].
    Berglund G; Hansson L
    Lakartidningen; 1971 Oct; 68(44):5009-12. PubMed ID: 5135956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.